A combination treatment using a personalized cancer vaccine and immunotherapy drug reduced melanoma recurrence and death risk by 49 percent in patients monitored five years after surgery, according to new clinical data. The sustained benefit suggests a meaningful advancement in preventing melanoma progression for patients with advanced disease.
Good News Network · Sunday, 7 June 2026
The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence and death by 49 percent, a new study shows. This reduction was calculated five years after patients had their tumors surgically removed and remains unchanged. Led […] The post Cancer Vaccine Produces 49% Melanoma Reduction in Patients Five Years Later appeared first on Good News Network.
Original source
Read the full article at Good News NetworkShare this story
Volunteer physicians in La Guaira rapidly repurposed a fast-food restaurant to provide medical care following a seismic event, extending healthcare access when conventional facilities were unavailable. The improvised clinic demonstrates community resilience and medical innovation in resource-constrained conditions.
Al Jazeera · 11 Jul
Pakistan's Supreme Court issued comprehensive anti-harassment guidelines for educational institutions and upheld strict penalties against a headmistress who failed to protect female teachers from sexual harassment. The ruling requires all schools to adopt internal harassment policies, establish independent complaint mechanisms, and display codes of conduct across the country.
Dawn Pakistan · 11 Jul
Brazil's Amazon deforestation fell to its lowest level in ten years, reflecting strengthened enforcement against illegal logging and forest clearing. The milestone supports Lula's commitment to eliminate illegal deforestation by 2030, with implications for global climate and biodiversity.
Al Jazeera · 10 Jul
Every Sunday — the week's most uplifting stories, straight to your inbox. No doom, no noise.
No spam. Unsubscribe anytime. GDPR compliant.